MetaCap

Burning Rock Biotech Insider Trades

NASDAQ: BNRHealth CareMedical SpecialitiesUSD

15.49+0.49 (+3.27%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
8 · $11.65M
Sales
0 · $0
Shares bought / sold
1.05M / 0
Net activity
Net buying $11.6 million

Burning Rock Biotech insider activity

Over the last 12 months, Burning Rock Biotech insiders reported 8 transactions on SEC Form 4: 8 open-market purchases and 0 sales. Insiders bought $11.6 million and sold $0 worth of stock, for net insider buying of $11.6 million. The most recent filing shows Han Yusheng (Director) buying 24,900 shares at $8.00 on Jun 26, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BNR's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

BNR insider transactions

Burning Rock Biotech insider transactions
DateInsiderTypeSharesValueFiling
Jun 26, 2026Han YushengDirectorBuy24,900$199.09KForm 4
Jun 24, 2026Han YushengDirectorBuy250,000$2.00MForm 4
Jun 23, 2026Han YushengDirectorBuy5,990$44.92KForm 4
Jun 22, 2026Han YushengDirectorBuy104,650$779.67KForm 4
Jun 16, 2026Han YushengDirectorBuy111,110$999.96KForm 4
Jun 12, 2026Han YushengDirectorBuy210,000$1.94MForm 4
Jun 11, 2026Han YushengDirectorBuy24,760$216.39KForm 4
Mar 31, 2026Han YushengDirectorBuy314,870$5.47MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related